AzTrials
AzTrials

Periodontal Intrabony DefectsPRTNCT07763223

Sub-junctional Pinhole Technique

A study testing Sub-junctional Pinhole Technique (S-PHT) in people with Periodontal Intrabony Defects and Stage III Grade B Periodontitis, run by Al-Azhar University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pinhole Regenerative Therapy (PRT) following minimally invasive non-surgical periodontal therapy (MINST) in the treatment of intrabony defects associated with Stage III Grade B periodontitis. Eligible patients with 2- or 3-wall intrabony defects will be randomly allocated to the study groups. Read more about this study

Who is it for?
Ages 39 to 61 yearsHealthy volunteers can take part
What is being tested?
Sub-junctional Pinhole Technique (S-PHT)
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteEgypt
Study dates
30 Jun 2024to 27 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 39 to 61 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients aged 39-61 years.
  • Systemically healthy patients.
  • Diagnosed with Stage III periodontitis.
  • Presence of probing pocket depth (PPD) ≥ 6 mm.
  • Presence of clinical attachment loss (CAL) ≥ 4 mm.
  • Presence of at least one 2- or 3-wall interproximal intrabony defect with:
Show all 9Show fewer
  • Defect depth ≥ 3 mm.
  • Angulation width ≥ 45°.
  • Each participant contributed one maxillary or mandibular single- or multi-rooted interproximal intrabony defect.

Who cannot join

  • Patients with any systemic condition contraindicating surgical intervention.
  • Pregnant or lactating females.
  • Smokers.
  • Alcoholic patients.
  • History of periodontal therapy within the previous 6 months.
  • History of antibiotic administration within the previous 6 months.
  • Patients with unacceptable oral hygiene after re-evaluation following Step 1 and Step 2 periodontal therapy.
  • Teeth with any degree of mobility.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Department of Periodontology, Faculty of Dentistry, Al-Azhar University, Cairo, Egypt

    Cairo, Nasr City, 11675

Other trials in Egypt

About this study

Official title: A Novel Approach of Pinhole Regenerative Therapy (PRT) in Treating Stage III Periodontitis

Pinhole Regenerative Therapy (PRT) following minimally invasive non-surgical periodontal therapy (MINST) in the treatment of intrabony defects associated with Stage III Grade B periodontitis. Eligible patients with 2- or 3-wall intrabony defects will be randomly allocated to the study groups. Clinical outcomes, including probing pocket depth (PPD) reduction and clinical attachment level (CAL) gain, together with radiographic bone defect fill assessed by periapical radiographs and CBCT, will be evaluated over a 6-month follow-up period to determine the effectiveness of the proposed minimally invasive regenerative approacا

Read the detailed description

Periodontal intrabony defects associated with Stage III periodontitis remain a major clinical challenge because conventional surgical approaches may require extensive flap reflection, which can compromise soft tissue support and increase patient morbidity. Minimally invasive periodontal therapy has been introduced to preserve soft tissues while maintaining favorable clinical outcomes.

This randomized controlled clinical trial is designed to evaluate the efficacy of a novel Pinhole Regenerative Therapy (PRT) in the treatment of intrabony periodontal defects. The proposed technique is based on minimally invasive non-surgical periodontal therapy (MINST) followed by a minimally invasive pinhole approach for defect degranulation and regenerative graft placement without flap elevation. The technique is intended to maximize preservation of the surrounding soft tissues while promoting periodontal regeneration.

Patients diagnosed with Stage III Grade B periodontitis presenting with 2- or 3-wall intrabony defects will be recruited from the outpatient clinics of the Department of Oral Medicine and Periodontology, Faculty of Dental Medicine, Al-Azhar University. Eligible participants will be randomly allocated to the study groups according to the study protocol.

The primary outcome is radiographic intrabony defect fill assessed using periapical radiographs and cone beam computed tomography (CBCT). Secondary outcomes include probing pocket depth (PPD) reduction and clinical attachment level (CAL) gain. Clinical parameters will be recorded at baseline, 3 months, and 6 months, while radiographic evaluation will be performed at baseline and 6 months.

Being tested
Sub-junctional Pinhole Technique (S-PHT)
Keywords
Stage III Periodontitis, Pinhole Regenerative Therapy (PRT), Periodontal Regeneration, Periodontal Therapy
Medical subject headings
Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sub-junctional Pinhole Technique (S-PHT)Procedure or surgery

    Four weeks after minimally invasive non-surgical therapy (MINST), intrabony defects were accessed through a small facial pinhole. Defect degranulation was performed using minimally invasive ultrasonic and hand instruments, followed by placement of hydrated xenogenic bone graft (Geistlich Bio-Oss) through the same pinhole without flap elevation

Study groups in NCT07763223
Study groupRoleWhat they receive
Sub-junctional Pinhole Technique (S-PHT)ExperimentalParticipants with Stage III periodontitis and intrabony defects received minimally invasive non-surgical periodontal therapy (MINST), followed 4 weeks later by sub-junctional pinhole technique (S-PHT), including minimally invasive defect degranulation and xenogenic bone graft placement through a facial pinhole without flap elevation
Receives: Procedure: Sub-junctional Pinhole Technique (S-PHT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Composite Clinical Outcome

    Composite outcome of pocket closure ≤4 mm, clinical attachment level ,gain ≥3 mm, and absence of bleeding on probing .

    Measured: 9 months

Secondary outcomes (4)
  1. Probing Pocket Depth

    Change in probing pocket depth measured using a University of North Carolina periodontal probe.

    Scale: 1 -10 mm

    Measured: Base line ( day one ), and at nine months

  2. Clinical Attachment Level (CAL)

    Change in clinical attachment level measured using a university of north carolina-15 periodontal probe.

    Scale: 1 -10 mm

    Measured: Base line ( day one ), and at nine months

  3. Patient Satisfaction (Postoperative Pain)

    Postoperative pain assessed using a 10-cm Visual Analog Scale .

    Measured: Immediately after surgery, Day 1, Day 2, and Day 3

  4. Operation Chair Time

    Duration of the operative procedure recorded in minutes.

    Measured: During the Intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2026
  2. Study start30 Jun 2024
  3. Primary completion25 Apr 2025
  4. Study completion27 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Eligible patients with Stage III Grade B periodontitis and intrabony defects will be randomly assigned to the study groups in a parallel design to evaluate minimally invasive non-surgical therapy with or without the proposed pinhole regenerative
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07763223
Sponsor's protocol ID
PRT-RCT-2026-001
Acronym
PRT
Status last verified
Aug 2026
First submitted
5 Aug 2026
Last updated
19 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Sub-junctional Pinhole Technique (S-PHT) in people with Periodontal Intrabony Defects and Stage III Grade B Periodontitis, run by Al-Azhar University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Composite Clinical Outcome (time frame: 9 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in